Literature DB >> 2174560

cAMP inhibits induction of interleukin 2 but not of interleukin 4 in T cells.

T J Novak1, E V Rothenberg.   

Abstract

In this report, we explore the nature of the inductive stimuli leading to expression of the divergently regulated lymphokines interleukin 2 (IL-2) and interleukin 4 (IL-4). Elevation of cAMP levels blocks IL-2 induction while sparing IL-4 induction. These effects are gene-specific, not cell-specific, and can be observed in the same cells. Transient transfection experiments using murine IL-2 regulatory sequences to drive expression of a reporter gene show at least part of the inhibition to act at the transcriptional level. The possible biological significance of these results is indicated by the observation that representative type 2 helper T-cell lines maintain significantly higher levels of cAMP per cell than a type 1 helper T-cell line. Fresh splenic CD4+ T cells, which preferentially make IL-2, have particularly low levels of cAMP per cell and a low capacity to elevate cAMP in response to forskolin. However, their response to forskolin increases significantly after several days of stimulation. These results suggest a potential link between differential cAMP regulation and the divergence of memory T cells into effector subsets.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2174560      PMCID: PMC55163          DOI: 10.1073/pnas.87.23.9353

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

Review 1.  Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy.

Authors:  D L Mueller; M K Jenkins; R H Schwartz
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

Review 2.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.

Authors:  T R Mosmann; R L Coffman
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

3.  Suppressor effects and cyclic AMP accumulation by the CD29 molecule of CD4+ lymphocytes.

Authors:  H Groux; S Huet; H Valentin; D Pham; A Bernard
Journal:  Nature       Date:  1989-05-11       Impact factor: 49.962

4.  Contingent genetic regulatory events in T lymphocyte activation.

Authors:  G R Crabtree
Journal:  Science       Date:  1989-01-20       Impact factor: 47.728

5.  Mast cell lines produce lymphokines in response to cross-linkage of Fc epsilon RI or to calcium ionophores.

Authors:  M Plaut; J H Pierce; C J Watson; J Hanley-Hyde; R P Nordan; W E Paul
Journal:  Nature       Date:  1989-05-04       Impact factor: 49.962

6.  Transcription maps of polyoma virus-specific RNA: analysis by two-dimensional nuclease S1 gel mapping.

Authors:  J Favaloro; R Treisman; R Kamen
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

7.  Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway.

Authors:  T Lindstein; C H June; J A Ledbetter; G Stella; C B Thompson
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

8.  Influence of activating stimulus on functional phenotype: interleukin 2 mRNA accumulation differentially induced by ionophore and receptor ligands in subsets of murine T cells.

Authors:  K L McGuire; J A Yang; E V Rothenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

9.  Thymoma production of T cell growth factor (Interleukin 2).

Authors:  J J Farrar; J Fuller-Farrar; P L Simon; M L Hilfiker; B M Stadler; W L Farrar
Journal:  J Immunol       Date:  1980-12       Impact factor: 5.422

10.  Protein kinase C-dependent and -independent mechanisms of cloned murine T cell proliferation. The role of protein kinase C translocation and protein kinase C activity.

Authors:  D K Kim; D W Lancki; F H Hui; F W Fitch
Journal:  J Immunol       Date:  1989-01-15       Impact factor: 5.422

View more
  39 in total

Review 1.  Autonomic regulation of neuroimmunological responses: implications for multiple sclerosis.

Authors:  E M Frohman; N L Monson; A E Lovett-Racke; M K Racke
Journal:  J Clin Immunol       Date:  2001-03       Impact factor: 8.317

2.  Interleukin 2 promoter/enhancer controlled expression of a synthetic cecropin-class lytic peptide in transgenic mice and subsequent resistance to Brucella abortus.

Authors:  W A Reed; P H Elzer; F M Enright; J M Jaynes; J D Morrey; K L White
Journal:  Transgenic Res       Date:  1997-09       Impact factor: 2.788

Review 3.  Sympathetic modulation of immunity: relevance to disease.

Authors:  Denise L Bellinger; Brooke A Millar; Sam Perez; Jeff Carter; Carlo Wood; Srinivasan ThyagaRajan; Christine Molinaro; Cheri Lubahn; Dianne Lorton
Journal:  Cell Immunol       Date:  2008-03-04       Impact factor: 4.868

Review 4.  Mechanisms of regulatory T-cell suppression - a diverse arsenal for a moving target.

Authors:  Dorothy K Sojka; Yu-Hui Huang; Deborah J Fowell
Journal:  Immunology       Date:  2008-03-14       Impact factor: 7.397

5.  Differential regulation of IFN-gamma, IL-10 and inducible nitric oxide synthase in human T cells by cyclic AMP-dependent signal transduction pathway.

Authors:  N Benbernou; S Esnault; H C Shin; H Fekkar; M Guenounou
Journal:  Immunology       Date:  1997-07       Impact factor: 7.397

6.  In vitro effects of oxpentifylline on inflammatory cytokine release in patients with inflammatory bowel disease.

Authors:  J M Reimund; S Dumont; C D Muller; J S Kenney; M Kedinger; R Baumann; P Poindron; B Duclos
Journal:  Gut       Date:  1997-04       Impact factor: 23.059

7.  TAK-603 selectively suppresses Th1-type cytokine production and inhibits the progression of adjuvant arthritis.

Authors:  Y Ohta; M Yamane; T Sohda; H Makino
Journal:  Immunology       Date:  1997-09       Impact factor: 7.397

Review 8.  T regulatory cells in B-cell malignancy - tumour support or kiss of death?

Authors:  Camilla A Lindqvist; Angelica S I Loskog
Journal:  Immunology       Date:  2012-04       Impact factor: 7.397

9.  cAMP activates the generation of reactive oxygen species and inhibits the secretion of IL-6 in peripheral blood mononuclear cells from type 2 diabetic patients.

Authors:  Camila Armond Isoni; Erica Abreu Borges; Clara Araújo Veloso; Rafael Teixeira Mattos; Miriam Martins Chaves; José Augusto Nogueira-Machado
Journal:  Oxid Med Cell Longev       Date:  2009 Nov-Dec       Impact factor: 6.543

10.  Lipoic acid attenuates inflammation via cAMP and protein kinase A signaling.

Authors:  Sonemany Salinthone; Vijayshree Yadav; Robynn V Schillace; Dennis N Bourdette; Daniel W Carr
Journal:  PLoS One       Date:  2010-09-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.